Key Points Biomarker panels at GVHD onset, independently from clinical parameters, were associated with survival and nonrelapse mortality. Using 3 different biostatistical tools, biomarkers only slightly improved prediction over clinical… Click to show full abstract
Key Points Biomarker panels at GVHD onset, independently from clinical parameters, were associated with survival and nonrelapse mortality. Using 3 different biostatistical tools, biomarkers only slightly improved prediction over clinical parameters.
               
Click one of the above tabs to view related content.